Lidoderm

Lidoderm is a brand name of lidocaine topical, approved by the FDA in the following formulation(s):

LIDODERM (lidocaine - patch; topical)

• 
  Manufacturer: TEIKOKU PHARMA USA
  
  Approval date: March 19, 1999
  
  Strength(s): 5% ^[RLD]

Has a generic version of Lidoderm been approved?

No. There is currently no therapeutically equivalent version of Lidoderm available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Lidoderm. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine
  Patent 5,411,738
  Issued: May 2, 1995
  Inventor(s): Hind; Harry
  Assignee(s): Hind Health Care, Inc.
  Methods and compositions are offered for reducing nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia), where intradermal delivery of lidocaine is maintained for a predetermined period of time. The lidocaine appears to specifically affect the damaged nerve fibers, while leaving the undamaged and normal nerve fibers with retention of response to other stimuli. Lidocaine formulations are provided which allow for the necessary dosage of the lidocaine in the dermis during the period of treatment. The formulation may be covered with an occlusive or non-occlusive dressing, which protects the lidocaine formulation from mechanical removal and enhances the transport of the lidocaine into the dermis. Long term relief is realized after maintenance of the administration of lidocaine has been terminated.
  
  Patent expiration dates:
  
  
  • May 2, 2012
    
  
  



• 
  Method for treating pain associated with herpes-zoster and post-herpetic neuralgia
  Patent 5,601,838
  Issued: February 11, 1997
  Inventor(s): Hind; Harry
  Assignee(s): Hind Health Care, Inc.
  A method is offered for reducing the pain associated with herpes-zoster and post-herpetic neuralgia. The method consists of administering a composition incorporating a transdermal delivery system for the administration of Lidocaine to areas of the body afflicted by herpes-zoster and post-herpetic neuralgia enclosed with an occlusive dressing or a plaster dressing.
  
  Patent expiration dates:
  
  
  • May 2, 2012
    
    ✓ 
    Patent use: METHOD FOR REDUCING THE PAIN ASSOCIATED WITH HERPES-ZOSTER AND POST-HERPETIC NEURALGIA
  
  



• 
  Adhesive patch for applying analgesic medication to the skin
  Patent 5,741,510
  Issued: April 21, 1998
  Inventor(s): Rolf; David & Sjoblom Urmann; Elisabeth K.
  Assignee(s): Lectec Corporation
  A medication patch to be applied to the skin includes a self-supporting backing layer to give the patch the required integrity and strength by acting as a supporting framework for other components, and a flexible hydrophilic pressure-sensitive adhesive reservoir comprising a natural or synthetic polymer for the sustained release of medication to be absorbed topically through the skin into the body of a patient. The reservoir has two portions: first, an external coating layer with an exposed lower skin-contacting surface that forms a pressure-sensitive bond with the skin, and second, an upper internal portion which infiltrates the porous backing and becomes solidified therein after being applied so that the reservoir and the backing are unified, enabling the backing itself to act as a storage location for the medication-containing reservoir. The medication within the reservoir migrates over time from within the backing through the lower coating layer and passes through the skin to provide sustained release of the medication into the body of a patient.
  
  Patent expiration dates:
  
  
  • March 30, 2014
    
    ✓ 
    Drug product
  
  



• 
  External preparation for application to the skin containing lidocaine
  Patent 5,827,529
  Issued: October 27, 1998
  Inventor(s): Ono; Masahiro & Akazawa; Mitsuji & Seki; Michiko & Iwamoto; Kiyomi & Konishi; Ryoji
  Assignee(s): Teikoku Seiyaku Kabushiki Kaisha
  An external preparation for application to the skin containing lidocaine which comprises a drug-retaining layer placed on a support, wherein said drug-retaining layer comprises an adhesive gel base and 1 to 10% by weight of lidocaine, said base comprising a water-soluble high molecular weight substance, water and a water-retaining agent, which can release the active lidocaine gradually and constantly so that lidocaine is transdermally absorbed for a long period of time.
  
  Patent expiration dates:
  
  
  • October 27, 2015
    
    ✓ 
    Patent use: EXTERNAL PREPARATION FOR APPLICATION TO THE SKIN CONTAINING LIDOCAINE-DRUG RETAINING LAYER PLACED ON SUPPORT AND COMPRISES ADHESIVE GEL BASE 1-10% BY WEIGHT OF LIDOCAINE
  
  

See also...

• Lidoderm Consumer Information (Drugs.com)
• Lidoderm Patch Consumer Information (Wolters Kluwer)
• Lidoderm Consumer Information (Cerner Multum)
• Lidoderm Topical application Advanced Consumer Information (Micromedex)
• Lidocaine Aerosol Consumer Information (Wolters Kluwer)
• Lidocaine Cream Consumer Information (Wolters Kluwer)
• Lidocaine Foam Consumer Information (Wolters Kluwer)
• Lidocaine Gel Consumer Information (Wolters Kluwer)
• Lidocaine Intradermal System Consumer Information (Wolters Kluwer)
• Lidocaine Liquid Consumer Information (Wolters Kluwer)
• Lidocaine Lotion Consumer Information (Wolters Kluwer)
• Lidocaine Ointment Consumer Information (Wolters Kluwer)
• Lidocaine Patch Consumer Information (Wolters Kluwer)
• Lidocaine Solution Consumer Information (Wolters Kluwer)
• Xylocaine Solution Consumer Information (Wolters Kluwer)
• Zilactin L Liquid Consumer Information (Wolters Kluwer)
• Zilactin-L Consumer Information (Cerner Multum)
• Lidocaine topical Consumer Information (Cerner Multum)
• Burn-O-Jel Topical application Advanced Consumer Information (Micromedex)
• Burnamycin Topical application Advanced Consumer Information (Micromedex)
• Solarcaine First Aid Lidocaine Spray Topical application Advanced Consumer Information (Micromedex)
• Solarcaine Lidocaine First Aid Spray Topical application Advanced Consumer Information (Micromedex)
• Xylocaine Topical application Advanced Consumer Information (Micromedex)
• Lidocaine Topical application Advanced Consumer Information (Micromedex)